Clinical Trial Update: Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a gonadotropin-releasing hormone agonist for preserving ovarian function during chemotherapy in premenopausal breast cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Goserelin (Goserelin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED